MedTrace Logo

STIMTAVI : Evolution of Atrioventricular Conduction Disorders After TAVI

NCT03338582 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 275

Last updated 2017-11-09

No results posted yet for this study

Summary

The investigators propose to carry out an observational study of patients implanted with a pacemaker using AAI SafeR® mode after a TAVI procedure. This study aims to define the persistence or not of high-grade AVB beyond seven days after the procedure, based on the analysis of PM memories, and define definitive cardiac pacing indications after TAVI procedure.

Conditions

  • Pacemaker Implantation
  • TAVI

Sponsors & Collaborators

  • LivaNova

    collaborator INDUSTRY

  • Association de Recherche en Cardiologie des Alpes

    lead OTHER

Principal Investigators

  • Didier IRLES, Dr · Association de Recherche en Cardiologie des Alpes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-01
Primary Completion
2018-01-19
Completion
2018-04-19

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03338582 on ClinicalTrials.gov